Drug intelligence / Profile preview

bee venom + honey

Development stage
Preclinical
Lead developer
Apimeds
Administration
Topical, Oral
01

Overview

Bee venom + honey is a combination of two natural bee-derived substances used in traditional and alternative medicine, particularly within the practice of apitherapy. Bee venom contains bioactive peptides such as melittin, apamin, and adolapin, which have demonstrated anti-inflammatory, pain-relieving, antioxidant, antibacterial, antiviral, and anticancer properties. Honey is well known for its antimicrobial activity and wound-healing effects. The combination is sometimes used topically or in other formulations to leverage both the anti-inflammatory effects of bee venom and the healing properties of honey. While each component has been studied individually for various indications—including arthritis symptom relief (bee venom) and wound care (honey)—the specific combination is primarily found in complementary medicine rather than mainstream pharmaceutical use. Mechanistically, bee venom acts by modulating inflammatory pathways (e.g., suppressing TNF-α and IL-1β), stimulating immune responses, providing local analgesia via peptide action on nerve cells, while honey provides a moist environment conducive to tissue repair with additional antimicrobial protection[1][2][4][5].

02

Targets

IL1B (Interleukin-1 beta)TNFA (Tumor necrosis factor alpha (soluble))

Beyond the preview

Go deeper on bee venom + honey.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on bee venom + honey.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call